The Importance of Site Selection: Parkinson's biomarker quest offers case study.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 12
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2020 AND VI 29 AND IP 3
Results: 14
1
2
UNTAPPED OPPORTUNITY TO IMPROVE THE VENDOR QUALIFICATION PROCESS: Study holds new benchmarks and improvement opportunities.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 10
- By:
- Publication type:
- Article
3
THE FUTURE OF CLINICAL TRIALS: PREDICTIONS FOR REST OF 2020.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 9
- By:
- Publication type:
- Article
4
THE PRACTICE & PROMISE OF DATA SCIENCE IN CLINICAL TRIALS.
- Published in:
- 2020
- Publication type:
- Interview
5
Do-it-Yourself Blood Sampling for Pediatric Clinical Trials: Evaluating efforts to obtain youth and parent perspectives on the concept of microsampling in pediatric clinical trials.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 20
- By:
- Publication type:
- Article
6
Data Management Landscape is Still Changing, Are We Adapting Fast Enough?
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 26
- By:
- Publication type:
- Article
7
Investing in Data Science to Unlock Clinical Data Value: The need for biopharma companies to equip data managers with the training and resources necessary to capitalize on new digital health tools.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 18
- By:
- Publication type:
- Article
8
Scalability: Solving the Unique Clinical Trial Data Problem: Finding a middle-ground approach to balancing new solutions arising from data science with traditional requirements for data collection and submission.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 16
- By:
- Publication type:
- Article
9
Clinical Data Manager: A Roadmap for the Future: Breaking down the evolving role of today's clinical data manager--and its importance as a key cog in the clinical research ecosystem of tomorrow.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 14
- By:
- Publication type:
- Article
10
GILEAD TO ACQUIRE FORTY SEVEN FOR $4.9 BILLION.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 6
- Publication type:
- Article
11
INTEGRATING DATA INTO DRUG DECISION-MAKING.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 6
- By:
- Publication type:
- Article
12
Three Key Takeaways from SCOPE.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 2
- By:
- Publication type:
- Article
13
EU SPECIALISTS: EASE THE AGE BARRIER FOR CANCER CLINICAL TRIALS.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 5
- By:
- Publication type:
- Article
14
ONCOLOGY THERAPIES POISED FOR FURTHER GAINS AT FDA.
- Published in:
- Applied Clinical Trials, 2020, v. 29, n. 3, p. 4
- By:
- Publication type:
- Article